Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North central cancer treatment group results

Journal of Clinical Oncology

Volumn 16, Issue 9, 1998, Pages 2953-2958

  Galanis, Evanthia ^b   Buckner, Jan C ^a   Burch, Patrick A ^b   Schaefer, Paul L ^b   Dinapoli, Robert P ^b   Novotny, Paul J ^b   Scheithauer, B W ^b   Rowland, Kendrith M ^b   Vukov, Allen M ^b   Mailliard, James A ^b   Morton, Roscoe F ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORMETHINE; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUTROPENIA; OLIGODENDROGLIOMA; PRIORITY JOURNAL; SKIN MANIFESTATION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0031692882     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.9.2953     Document Type: Article

References (26)

1. Fine HA, Dear KBG, Loeffler JS, et al: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71:2585-2597, 1993
2. Wilson CB, Gutin PH, Boldrey EB, et al: Single-agent chemotherapy of brain tumors. Arch Neurol 33:739-744, 1976
3. Hoogstraten B, Gottlieb JA, Caoili E: CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer: Phase II study. Cancer 32:38-43, 1973
4. Rosenblum ML, Reynolds AF, Smith KA, et al: Chloroethylcyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors. J Neurosurg 39:306-314, 1973
5. Levin VA, Resser K, McGrath L, et al: PCNU treatment for recurrent malignant gliomas. Cancer Treat Rep 68:969-973, 1984
6. Kumar ARV, Renaudin J, Wilson CB, et al: Procarbazine hydrochloride in the treatment of brain tumors. J Neurosurg 40:365-371, 1974
7. EORTC Brain Tumor Group: Evaluation of CCNU. VM-26 plus CCNU. and procarbazine in supratentorial brain gliomas. J Neurosurg 55:27-31, 1981
8. Rodriguez LA, Prados M, Silver P, et al: Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors. Cancer 64:2420-2423, 1989
9. Chamberlain MC, Prados MD, Silver P, et al: A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors. J Neurooncol 6:319-323, 1988
10. Schold SC, Friedman HS, Bjornsson TD, et al: Treatment of patients with recurrent primary brain tumors with AZQ. Neurology 34:615-619, 1984
11. Chamberlain MC, Prados MD, Silver P, et al: A phase II trial of oral melphalan in recurrent primary brain tumors. Am J Clin Oncol 11:52-54, 1988
12. Bertolone SJ, Baum ES, Krivit W, et al: A phase II study of cisplatin therapy in recurrent childhood brain tumors. J Neurooncol 7:5-11, 1989
13. Yung WK, Mechtler L, Gleason MJ: Intravenous carboplatin for recurrent malignant gliomas: a phase II study. J Clin Oncol 9:860-864, 1991
14. Cangir A, Van Eys J, Berry DH, et al: Combination chemotherapy with MOPP in children with recurrent brain tumors. Med Pediatr Oncol 4:253-261, 1978
15. Van Eys J, Baram T, Cangir A, et al: Salvage chemotherapy for recurrent primary brain tumors in children. J Pediatr 113:601-606, 1988
16. Van Eys J, Cangir A, Coody D, et al: MOPP regimen as primary chemotherapy for brain tumors in infants. J Neurooncol 3:237-243, 1985
17. Cangir A, Ragub A, Steuber P: Combination chemotherapy with vincristine (NSC 67574), procarbazine (NSC-77213) prednisone (NSC 10023) with or without nitrogen mustard (NSC 762) (MOPP vs OPP) in children with recurrent brain tumors. Med Pediatr Oncol 12:1-3, 1984
18. Coyle T, Baptista J, Winfield J, et al: Mechlorethamine, vincristine, and procarbazine chemotherapy for recurrent high-grade glioma in adults: A phase II study. J Clin Oncol 8:2014-2018, 1990
19. NCI: Common Toxicity Criteria. Bethesda, MD, National Cancer Institute, Division of Cancer Treatment, 1988
20. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
21. Peto R, Peto J: Asymptotically efficient rank invariant procedures (with discussion). J R Stat Soc A 135:185-207, 1972
22. Cairncross G, Macdonald D, Ludwin S, et al: Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 12:2013-2021, 1994
23. Kyritsis AP, Yung WKA, Bruner J, et al: The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 32:365-371, 1993
24. Mason WP, Krol GS, DeAngelis LM: Low-grade oligodendroglioma responds to chemotherapy. Neurology 46:203-207, 1996
25. Buckner JC, Brown LD, Cascino TL, et al: Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma. J Neurosurg 82:52-57, 1995
26. Brada M, Sharpe G: Chemotherapy of high-grade gliomas: Beginning of a new era or the end of the old? Eur J Cancer 32A:2193-2194, 1996